Search

Your search keyword '"Kleine-Tebbe, J."' showing total 578 results

Search Constraints

Start Over You searched for: Author "Kleine-Tebbe, J." Remove constraint Author: "Kleine-Tebbe, J."
578 results on '"Kleine-Tebbe, J."'

Search Results

101. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma:An EAACI position paper

102. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

104. Allergen immunotherapy for the prevention of allergy: A systematic review and meta-analysis

105. Allergen immunotherapy for allergic asthma: protocol for a systematic review (vol 6, 5, 2016)

106. Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie – ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion) * – Positionspapier der deutschen ARIA-GruppeA in Kooperation mit der österreichischen ARIA-GruppeB , der schweizerischen ARIA-GruppeC , dem Ärzteverband Deutscher Allergologen (AeDA)D , der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)E und der Gesellschaft für Pädiatrische Allergologie (GPA)F in Kooperation mit der AG Klinische Immunologie, Allergologie und Umweltmedizin der DGHNO-KHCG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H

110. Marker allergens and panallergens in tree and grass pollen allergy

111. Abstract of the AWMF-Guideline medical clinical Diagnostics of Mold Fungus Exposure in Indoor Rooms

112. Biomarkers for Monitoring Clinical Efficacy of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Allergic Asthma:an EAACI Position Paper

113. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

114. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

115. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

116. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

117. EAACI molecular allergology user's guide

118. EAACI molecular allergology user's guide

119. Allergy immunotherapy across the life cycle to promote active and healthy ageing: From research to policies

120. EAACI Molecular Allergology User's Guide

123. Kurzfassung der AWMF-Leitlinie medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen

127. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper

130. BASALIT trial: double‐blind placebo‐controlled allergen immunotherapy with rBet v 1‐FV in birch‐related soya allergy

131. House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies

132. Respiratory allergy caused by house dust mites: What do we really know?

133. EAACI Molecular Allergology User's Guide

134. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

135. Grass pollen allergy

136. Weed pollen allergy

137. Allergy immunotherapy across the life cycle to promote active and healthy ageing

138. Allergy immunotherapy across the life cycle to promote active and healthy ageing: From research to policies

139. Allergen immunotherapy for allergic asthma: Protocol for a systematic review

140. Medical Diagnostics for Mold Exposure Indoors

141. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

142. EAACI Molecular Allergology User's Guide

143. Allergy immunotherapy across the life cycle to promote active and healthy ageing:from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project

144. Allergen immunotherapy for allergic asthma: protocol for a systematic review

145. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

146. Negative Clinical Results from a Randomised, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy of Two Doses of Immunologically Enhanced, Grass Subcutaneous Immunotherapy Despite Dose-Dependent Immunological Response

147. Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen

148. Standardization of double blind placebo controlled food challenge with soy within a multicentre trial

150. The conformational IgE epitope profile of soya bean allergen Gly m 4

Catalog

Books, media, physical & digital resources